Prognostic impact of CD168 expression in gastric cancer (Q33854876)

29 July 2017

title

Prognostic impact of CD168 expression in gastric cancer (English)

1 reference

29 July 2017

Sumiya Ishigami

1

1 reference

29 July 2017

Shinichi Ueno

2

1 reference

29 July 2017

Yuka Nishizono

3

1 reference

29 July 2017

Masataka Matsumoto

4

1 reference

29 July 2017

Hiroshi Kurahara

5

1 reference

29 July 2017

Takaaki Arigami

6

1 reference

29 July 2017

Yasuto Uchikado

7

1 reference

29 July 2017

Tetsuro Setoyama

8

1 reference

29 July 2017

Hideo Arima

9

1 reference

29 July 2017

Kita Yoshiaki

10

1 reference

29 July 2017

Yuko Kijima

11

1 reference

29 July 2017

Masaki Kitazono

12

1 reference

29 July 2017

Shoji Natsugoe

13

1 reference

29 July 2017

language of work or name

English

0 references

publication date

24 March 2011

1 reference

full work available at URL

29 July 2017

https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-11-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

http://www.biomedcentral.com/1471-2407/11/106/abstract

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

http://www.biomedcentral.com/1471-2407/11/106

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

http://www.biomedcentral.com/content/pdf/1471-2407-11-106.pdf

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

https://europepmc.org/articles/PMC3076262

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

https://europepmc.org/articles/PMC3076262?pdf=render

28 November 2024

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21435222

http://link.springer.com/content/pdf/10.1186/1471-2407-11-106.pdf

28 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1186/1471-2407-11-106

http://link.springer.com/article/10.1186/1471-2407-11-106/fulltext.html

28 November 2024

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

http://link.springer.com/content/pdf/10.1186/1471-2407-11-106

28 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1186/1471-2407-11-106

28 November 2024

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

page(s)

106

1 reference

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Androgen receptor regulates CD168 expression and signaling in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

CD44 expression and hyaluronic acid binding of malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

Filling the mosaic of p53 actions: p53 represses RHAMM expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1471-2407-11-106

Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076262

Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21435222

12 December 2020

inferred from PubMed ID database lookup

Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21435222

12 December 2020

inferred from PubMed ID database lookup

The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21435222

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1019079801

0 references

Fatcat ID

release_7c7qrstg6zgz5k4ldbkx7wzzoe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7c7qrstg6zgz5k4ldbkx7wzzoe

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3076262

1 reference

29 July 2017

1 reference